
CAS 112208-01-2
:Formula:C87H159F9N10O19S
InChI:InChI=1S/C81H156N10O13S.3C2HF3O2/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-55-73(93)86-72(65-105-64-66(104-75(95)57-42-39-36-33-30-27-24-21-18-15-12-9-6-3)63-103-74(94)56-41-38-35-32-29-26-23-20-17-14-11-8-5-2)80(100)91-71(62-92)79(99)89-68(52-44-48-59-83)77(97)87-67(51-43-47-58-82)76(96)88-69(53-45-49-60-84)78(98)90-70(81(101)102)54-46-50-61-85;3*3-2(4,5)1(6)7/h66-72,92H,4-65,82-85H2,1-3H3,(H,86,93)(H,87,97)(H,88,96)(H,89,99)(H,90,98)(H,91,100)(H,101,102);3*(H,6,7)/t66?,67-,68-,69-,70-,71-,72-;;;/m0.../s1
InChI key:OMHVRUPOLLHATE-PXSLIBMESA-N
SMILES:CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O
Filtra per
Percentuale di purezza
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 5 prodotti.
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
Pam3CSK4 TFA
CAS:Pam3CSK4 TFAFormula:C87H159F9N10O19SPurezza:98%Colore e forma:SolidPeso molecolare:1852.33Ref: IN-DA01V4UI
1mg175,00€5mg493,00€10mg602,00€25mg1.122,00€50mg1.943,00€100mg3.301,00€250mg6.596,00€S-(2,3-Bis(palmitoyloxy)propyl)-N-palmitoyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine tri(trifluoroacetate salt)
CAS:S-(2,3-Bis(palmitoyloxy)propyl)-N-palmitoyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine tri(trifluoroacetate salt)Formula:C87H159F9N10O19SPurezza:98% xTFA saltPeso molecolare:1852.3Ref: IN-DG01287798
1mg172,00€5mg445,00€10mg698,00€25mg1.319,00€50mg2.200,00€100mg3.740,00€250mg7.480,00€Pam3CSK4 TFA
CAS:Pam3CSK4 TFA (Pam3Cys-Ser-(Lys)4 TFA) is a Toll-like receptor 1/2 agonist with EC50 of 0.47 ng/mL for human TLR1/2.Formula:C87H159F9N10O19SPurezza:96.4% - 99.01%Colore e forma:White SolidPeso molecolare:1852.3Pam3Csk4 (TFA)
CAS:Pam3Csk4 (Pam3) is a TLR1/2 agonist which when combined with the TLR3 agonist polyinosinic:polycytidylic acid (polyI:C), forms the adjuvant system known as L-pampo. L-pampo has demonstrated the ability to produce stronger antibody generation against Hepatis B Virus compared to Alum and takes part in cell-mediated immune responses for example leading to elevated multifunctional CD4+ T cells. It has also shown its potential in producing strong humoral and cellular immune responses as an adjuvant against SARS-CoV-2.Formula:C87H159F9N10O19SPurezza:Min. 95%Peso molecolare:1,852.3 g/mol




